Rocket One Inc. Operating Leases, Rent Expense
Rocket One Inc. (RKTO) had Operating Leases, Rent Expense of $2.73 thousand as of 2025-03-01, per its 10-K filed 2025-03-28.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2025-03-28
- Rocket One Inc. operating leases, rent expense for the quarter ending 2023-06-30 was $7.90K, a 50.64% decline year-over-year.
- Rocket One Inc. operating leases, rent expense for the quarter ending 2022-12-31 was $20.00K, a 42.86% increase year-over-year.
- Rocket One Inc. operating leases, rent expense for the quarter ending 2022-09-30 was $18.00K, a 200.00% increase year-over-year.
- Rocket One Inc. operating leases, rent expense for the quarter ending 2022-06-30 was $16.00K, a 15.79% decline year-over-year.
- Rocket One Inc. operating leases, rent expense for fiscal 2022 was $67.00K, a 42.55% increase from fiscal 2021.
- Rocket One Inc. operating leases, rent expense for fiscal 2021 was $47.00K, a 88.00% increase from fiscal 2020.
- Rocket One Inc. operating leases, rent expense for fiscal 2020 was $25.00K, a 21.88% decline from fiscal 2019.
- Rocket One Inc. operating leases, rent expense for fiscal 2019 was $32.00K, a 14.29% increase from fiscal 2018.
| Period end | Operating Leases, Rent Expense | Operating Leases, Rent Expense 3 month | Operating Leases, Rent Expense 3 month as first filed | Operating Leases, Rent Expense 6 month | Operating Leases, Rent Expense 8 month | Operating Leases, Rent Expense 9 month | Operating Leases, Rent Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2025-03-01 | $2.73K 10-K · filed 2025-03-28 | ||||||
| 2023-06-30 | $7.90K 10-Q · filed 2024-08-09 | $23.02K 10-Q · filed 2024-08-09 | |||||
| 2022-12-31 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $38.00K derived: sum of 2 quarters · filed 2023-03-31 | $54.00K derived: sum of 3 quarters · filed 2023-03-31 | $67.00K 10-K · filed 2023-03-31 | |||
| 2022-09-30 | $18.00K 10-Q · filed 2022-11-10 | $34.00K derived: sum of 2 quarters · filed 2022-11-10 | $47.00K 10-Q · filed 2022-11-10 | $62.00K derived: sum of 4 quarters · filed 2023-03-31 | |||
| 2022-06-30 | $16.00K 10-Q · filed 2022-08-12 | $29.00K 10-Q · filed 2022-08-12 | $44.00K derived: sum of 3 quarters · filed 2023-03-31 | $50.00K derived: sum of 4 quarters · filed 2023-03-31 | |||
| 2022-03-31 | $14.00K 10-Q · filed 2022-05-12 | $28.00K derived: sum of 2 quarters · filed 2023-03-31 | $34.00K derived: sum of 3 quarters · filed 2023-03-31 | $53.00K derived: sum of 4 quarters · filed 2023-03-31 | |||
| 2021-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $20.00K derived: sum of 2 quarters · filed 2023-03-31 | $39.00K derived: sum of 3 quarters · filed 2023-03-31 | $47.00K 10-K · filed 2023-03-31 | |||
| 2021-09-30 | $6.00K 10-Q · filed 2022-11-10 | $25.00K derived: sum of 2 quarters · filed 2022-11-10 | $33.00K 10-Q · filed 2022-11-10 | $38.00K derived: sum of 4 quarters · filed 2022-11-10 | |||
| 2021-06-30 | $19.00K 10-Q · filed 2022-08-12 | $26.00K 10-Q · filed 2022-08-12 | $32.00K derived: sum of 3 quarters · filed 2022-08-12 | $40.00K derived: sum of 4 quarters · filed 2022-08-12 | |||
| 2021-03-31 | $7.00K 10-Q · filed 2022-05-12 | $13.00K derived: sum of 2 quarters · filed 2022-05-12 | $21.00K derived: sum of 3 quarters · filed 2022-05-12 | $24.00K derived: sum of 4 quarters · filed 2022-05-12 | |||
| 2020-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $14.00K derived: sum of 2 quarters · filed 2022-03-30 | $17.00K derived: sum of 3 quarters · filed 2022-03-30 | $25.00K 10-K · filed 2022-03-30 | |||
| 2020-09-30 | $8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $11.00K derived: sum of 2 quarters · filed 2021-08-11 | $19.00K 10-Q · filed 2020-11-10 | $27.00K derived: sum of 4 quarters · filed 2021-08-11 | |||
| 2020-06-30 | $3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $11.00K 10-Q · filed 2021-08-11 | $19.00K derived: sum of 3 quarters · filed 2021-08-11 | $28.00K derived: sum of 4 quarters · filed 2021-08-11 | |||
| 2020-03-31 | $8.00K 10-Q · filed 2021-05-13 | $16.00K derived: sum of 2 quarters · filed 2021-05-13 | $25.00K derived: sum of 3 quarters · filed 2021-05-13 | $33.00K derived: sum of 4 quarters · filed 2021-05-13 | |||
| 2019-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $17.00K derived: sum of 2 quarters · filed 2021-03-16 | $25.00K derived: sum of 3 quarters · filed 2021-03-16 | $32.00K 10-K · filed 2021-03-16 | |||
| 2019-09-30 | $9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $17.00K derived: sum of 2 quarters · filed 2020-11-10 | $24.00K 10-Q · filed 2020-11-10 | $31.00K derived: sum of 4 quarters · filed 2020-11-10 | |||
| 2019-06-30 | $8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $15.00K 10-Q · filed 2020-08-13 | $22.00K derived: sum of 3 quarters · filed 2020-08-13 | $31.00K derived: sum of 4 quarters · filed 2020-08-13 | |||
| 2019-03-31 | $7.00K 10-Q · filed 2020-05-13 | $28.00K 10-Q · filed 2019-05-15 | $14.00K derived: sum of 2 quarters · filed 2020-05-13 | $23.00K derived: sum of 3 quarters · filed 2020-05-13 | $24.00K derived: sum of 4 quarters · filed 2020-05-13 | ||
| 2018-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $16.00K derived: sum of 2 quarters · filed 2020-03-02 | $17.00K derived: sum of 3 quarters · filed 2020-03-02 | $28.00K 10-K · filed 2020-03-02 | |||
| 2018-09-30 | $9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $10.00K derived: sum of 2 quarters · filed 2019-11-12 | $21.00K 10-Q · filed 2019-11-12 | ||||
| 2018-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $12.00K 10-Q · filed 2019-08-14 | |||||
| 2018-03-31 | $11.00K 10-Q · filed 2019-05-15 | ||||||
| 2017-12-31 | $11.00K 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |